Mary D. Ruppe

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Karl Insogna, Karine Briot, Erik A. Imel et al. · Journal of Bone and Mineral Research · 2018 · 329 citations · Full text

Sclerostin, Human Growth, Immunology +21

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia

Thomas O. Carpenter, Erik A. Imel, Mary D. Ruppe et al. · Journal of Clinical Investigation · 2014 · 311 citations · Full text

Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice

Lennart Mucke, Eliezer Masliah, William B. Johnson et al. · Brain Research · 1994 · 274 citations

Synaptic Plasticity, Neurodegenerative Diseases, Molecular Neuroscience +11

Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1.

Tony Wyss‐Coray, Longfei Feng, Eliezer Masliah et al. · PubMed · 1995 · 253 citations

Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23

Erik A. Imel, Xiaoping Zhang, Mary D. Ruppe et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 164 citations · Full text